FDA — authorised 6 October 2017
- Application: NDA208845
- Marketing authorisation holder: PACIRA PHARMS INC
- Status: approved
🇺🇸 Zilretta in United States
FDA authorised Zilretta on 6 October 2017
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Zilretta approved in United States?
Yes. FDA authorised it on 6 October 2017; FDA has authorised it.
Who is the marketing authorisation holder for Zilretta in United States?
PACIRA PHARMS INC holds the US marketing authorisation.